Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
5.77
+0.10 (1.76%)
At close: Feb 21, 2025, 4:00 PM
5.81
+0.04 (0.69%)
After-hours: Feb 21, 2025, 5:21 PM EST
Anbio Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 4.33 | 2.25 | 10.01 | 2.54 |
| Depreciation & Amortization | 0 | 0.01 | 0.01 | - |
| Loss (Gain) From Sale of Investments | -0.29 | -0.16 | -0.04 | - |
| Change in Accounts Receivable | -4.62 | -1.88 | 0.72 | -0.72 |
| Change in Inventory | - | 0.35 | -0.35 | - |
| Change in Accounts Payable | -0.83 | -0.58 | -0.48 | 1.89 |
| Change in Other Net Operating Assets | 0.76 | 0.91 | -5.41 | 0.47 |
| Operating Cash Flow | -0.63 | 0.9 | 4.45 | 4.18 |
| Operating Cash Flow Growth | - | -79.81% | 6.40% | - |
| Investment in Securities | 0.29 | 1.73 | -1.53 | - |
| Investing Cash Flow | 0.29 | 1.73 | -1.53 | - |
| Other Financing Activities | 0.1 | -0.04 | - | - |
| Financing Cash Flow | 0.1 | -0.04 | - | - |
| Net Cash Flow | -0.25 | 2.59 | 2.92 | 4.18 |
| Free Cash Flow | -0.63 | 0.9 | 4.45 | 4.18 |
| Free Cash Flow Growth | - | -79.81% | 6.40% | - |
| Free Cash Flow Margin | -6.67% | 13.38% | 18.90% | 94.42% |
| Free Cash Flow Per Share | -0.01 | 0.01 | - | - |
| Levered Free Cash Flow | -2.09 | 0.03 | 0.87 | - |
| Unlevered Free Cash Flow | -2.09 | 0.03 | 0.87 | - |
| Change in Net Working Capital | 4.68 | 1.21 | 5.51 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.